This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cavender, D. E. Articles by Ziff, M. Search for Related Content PubMed PubMed Citation Articles by Cavender, D. E. Articles by Ziff, M.

American Journal of Pathology, Vol 134, 551-560, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Endothelial cell activation induced by tumor necrosis factor and lymphotoxin

DE Cavender, D Edelbaum and M Ziff
Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas.

Alterations in the morphology and histochemistry of vascular endothelial cells (EC) have been repeatedly observed at sites of chronic inflammation and immune reactions. These changes, which are most prominent in the EC postcapillary venules present in areas with large lymphocytic infiltrates, include the acquisition of a columnar or cuboidal morphology, the development of ribonuclease-sensitive metachromasia, and an increase in intracellular organelles. Thus, EC at sites of inflammation appear to be activated and to demonstrate increased metabolic activity. This study reports that both tumor necrosis factor-alpha (TNF) and lymphotoxin (LT) can activate cultured human umbilical vein EC, as measured by: 1) increased adhesiveness for lymphocytes, 2) increased cell metabolism, as measured by RNA and protein synthesis, and 3) increased cell volume. Although gamma interferon (IFN-gamma) and interleukin-1 (IL-1) have been shown previously to stimulate EC adhesiveness for lymphocytes, these two cytokines had only marginal effects on EC RNA and protein synthesis, and both caused a decrease in EC volume. These findings suggest that TNF and LT play a role in the type of activation of EC in vivo that leads to the development of tall endothelium and increased lymphocyte emigration.

This article has been cited by other articles:

				H.-J. Kim, T. Kammertoens, M. Janke, O. Schmetzer, Z. Qin, C. Berek, and T. Blankenstein Establishment of Early Lymphoid Organ Infrastructure in Transplanted Tumors Mediated by Local Production of Lymphotoxin {alpha} and in the Combined Absence of Functional B and T Cells J. Immunol., April 1, 2004; 172(7): 4037 - 4047. [Abstract] [Full Text] [PDF]

				K. MURAKAMI, K. OKAJIMA, and M. UCHIBA The Prevention of Lipopolysaccharide-induced Pulmonary Vascular Injury by Pretreatment with Cepharanthine in Rats Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 57 - 63. [Abstract] [Full Text]

				R. Sacca, C. A. Cuff, W. Lesslauer, and N. H. Ruddle Differential Activities of Secreted Lymphotoxin-{alpha}3 and Membrane Lymphotoxin-{alpha}1{beta}2 in Lymphotoxin-Induced Inflammation: Critical Role of TNF Receptor 1 Signaling J. Immunol., January 1, 1998; 160(1): 485 - 491. [Abstract] [Full Text] [PDF]

				H. von Boehmer Lymphotoxins: From cytotoxicity to lymphoid organogenesis PNAS, August 19, 1997; 94(17): 8926 - 8927. [Full Text] [PDF]